India's Biocon names Peter Bains as group CEO (updated)

Syngene International

18/09/2023 14:40

(Adds details in para 2-4, background in 5)
       BENGALURU, Sept 18 (Reuters) - Indian drugmaker Biocon
Ltd  BION.NS  on Monday appointed Peter Bains as the group's
chief executive officer, effective immediately. 
    Bains, who was named as an independent director of the
Biocon board in December last year, stepped down on Monday to
assume the top charge, the company said in a statement.
        "Peter has a unique fit and profile for the role having
... a comprehensive understanding of the Biocon Group ... having
led Syngene for five years, (and) taking it through its very
successful IPO in 2015," said Kiran Mazumdar-Shaw, Biocon group
chairperson.
  
        Bains, the first-ever group CEO, will report directly to
Mazumdar-Shaw, the statement added.
  
        A graduate of the University of Sheffield in the UK,
Bains was associated with Biocon's research unit Syngene
International  SYNN.NS  from 2010 to 2016, according to the
company website. 
        He was named Syngene's CEO in April 2015, before
retiring from the post a year later. 
  
        
  
   

 (Reporting by Hritam Mukherjee in Bengaluru; Editing by
Shailesh Kuber and Sohini Goswami)
 ((Hritam.Mukherjee@thomsonreuters.com; X: @MukherjeeHritam;))